What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2021-11-22 compared with 2021-08-16 · 36 added, 19 removed, 27 unchanged (67% of the section changed)

3 unchanged sentences

on its behalf by the undersigned, thereunto duly authorized.

August 16, 2021

November 22, 2021

and Chief Financial Officer

Financial and Accounting Officer)

Certificate of Incorporation (1)

Certificate of Amendment to Certificate of Incorporation (1)

Certificate of Amendment to Certificate of Incorporation, dated October 1, 2018 (6)

Certificate of Amendment to Certificate of Incorporation, dated June 26, 2019 (7)

Certificate of Amendment to Certificate of Incorporation, dated July 24, 2020 (10)

Form of Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock (8)

Certificate of Elimination - Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock (4)

of Incorporation (1)

of Amendment to Certificate of Incorporation (1)

of Amendment to Certificate of Incorporation, dated October 1, 2018 (6)

of Amendment to Certificate of Incorporation, dated June 26, 2019 (7)

of Amendment to Certificate of Incorporation, dated July 24, 2020 (10)

of Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock (8)

of Elimination - Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock (4)

Amended and Restated Bylaws (9)

Specimen PAVmed Inc.

Common Stock Certificate (1)

Specimen PAVmed Inc.

Series W Warrant Certificate (1)

Series W Warrant Agreement, dated April 28, 2016, between Continental Stock Transfer & Trust Company and the Registrant (2)

Specimen PAVmed Inc.

W Warrant Agreement, dated April 28, 2016, between Continental Stock Transfer & Trust Company and the Registrant (2)

Series Z Warrant Certificate (3)

Amended and Restated Series Z Warrant Agreement, dated as of June 8, 2018, by and between PAVmed Inc.

and Continental Stock Transfer & Trust Company, as Warrant Agent (5)

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Certification of Principal Financial and Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Certification of Principal Executive Officer pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Certification of Principal Financial and Accounting Officer pursuant to 18 U.S.C.

and Restated Series Z Warrant Agreement, dated as of June 8, 2018, by and between PAVmed Inc.

and Continental Stock Transfer &

Trust Company, as Warrant Agent (5)

License Agreement, dated as of May 20, 2019, by and between PAVmed Inc.

and Lucid Diagnostics Inc.

Management Services Agreement, dated as of May 12, 2018, by and between PAVmed Inc.

and Lucid Diagnostics Inc.

Amendment to Management Services Agreement, dated as of March 1, 2019, by and between PAVmed Inc.

and Lucid Diagnostics Inc.

Second Amendment to Management Services Agreement, dated as of June 5, 2019, by and between PAVmed Inc.

and Lucid Diagnostics Inc.

Third Amendment to Management Services Agreement, dated as of July 20, 2020, by and between PAVmed Inc.

and Lucid Diagnostics Inc.

Fourth Amendment to Management Services Agreement, dated as of February 1, 2021, by and between PAVmed Inc.

and Lucid Diagnostics Inc.

Certification

of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Certification

of Principal Financial and Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Certification

of Principal Executive Officer pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of

Certification

of Principal Financial and Accounting Officer pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley

Instance Document

4 unchanged sentences

Taxonomy Extension Presentation Linkbase

Page Interactive Data File (embedded within the Inline XBRL document)

by reference to the Registrant’s Registration Statement on Form S-1 - SEC File No.

8 unchanged sentences

by reference to the Registrant’s Definitive Proxy Statement on Schedule 14A filed June 11, 2020

Incorporated by reference to the Lucid Diagnostics Inc.’

Registration Statement on Form S-1 - SEC File No.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information